Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis

Research output: Contribution to journalJournal articleResearchpeer-review

BACKGROUND: Several national guidelines recommend continuous use of antipsychotic medication after a psychotic episode in order to minimize the risk of relapse. However some studies have identified a subgroup of patients who obtain remission of psychotic symptoms while not being on antipsychotic medication for a period of time. This study investigated the long-term outcome and characteristics of patients in remission of psychotic symptoms with no use of antipsychotic medication at the 10-year follow-up.

METHODS: The study was a cohort study including 496 patients diagnosed with schizophrenia spectrum disorders (ICD 10: F20 and F22-29). Patients were included in the Danish OPUS Trial and followed up 10years after inclusion, where patient data was collected on socio-demographic factors, psychopathology, level of functioning and medication.

FINDINGS: 61% of the patients from the original cohort attended the 10-year follow up and 30% of these had remission of psychotic symptoms at the time of the 10-year follow up with no current use of antipsychotic medication. This outcome was associated with female gender, high GAF-F score, participation in the labour market and absence of substance abuse.

CONCLUSION: Our results describe a subgroup of patients who obtained remission while not being on antipsychotic medication at the 10-year follow-up. The finding calls for further investigation on a more individualized approach to long-term treatment with antipsychotic medication.

Original languageEnglish
JournalSchizophrenia Research
Pages (from-to)42-48
Publication statusPublished - 2017

    Research areas

  • Adolescent, Adult, Antipsychotic Agents, Female, Humans, Longitudinal Studies, Male, Middle Aged, Psychiatric Status Rating Scales, Psychotic Disorders, Recurrence, Treatment Outcome, Young Adult, Journal Article

ID: 188192314